Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-08
2009-08-18
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S146000, C548S152000, C546S139000, C546S152000, C546S184000, C544S111000, C544S135000, C544S242000, C544S359000, C514S231500, C514S252120, C514S311000, C514S336000
Reexamination Certificate
active
07576110
ABSTRACT:
Compounds of formula (I)are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
REFERENCES:
patent: 2004/0224952 (2004-11-01), Cowart et al.
patent: 2005/0171181 (2005-08-01), Wager et al.
patent: 2007/0078133 (2007-04-01), Liu et al.
patent: 491224 (1930-01-01), None
patent: 0 259 977 (1988-03-01), None
patent: 2 174 505 (2000-02-01), None
patent: 94/15928 (1994-07-01), None
patent: 00/44728 (2000-08-01), None
A.C.S. Symposium Series, V14, Table of Contents, (1987).
Aranyos, A., et al., “Novel Electron-Rich Bulky Phosphine Ligands Facilitate the Palladium-Catalyzed Preparation of Diaryl Ethers”,J. Am. Chem. Soc., 121:4369-4378 (1999).
Arrang, J.-M., et al., “Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor”,Nature, 302:832-837 (1983).
Arrang, J.-M., et al., “Highly potent and selective ligands for histamine H3-receptors”,Nature, 327:117-123 (1987).
Arrang, J.-M., et al., “Histamine H3receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations”,Eur. J. of Pharmacology, 188:219-227 (1990).
Gil-Av, E. & Shabtai, J., “Synthesis and Reactions of 3-Methylcyclobutene”,J. of Org. Chem., 29(2):257-262 (1964).
Barbier, A.J., et al., “Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3antagonist”,Brit. J. of Pharmacology, 143:649-661 (2004).
Baston, E. & Hartmann, R.W., “A New Route to 6-Arly-Substituted 3,4-Dihydronaphthalene Derivatives Via Pd (O)-Catalyzed Cross-Coupling Reaction of Aryl Zinc Chlorides With an Aryl Triflate”,Synth. Comm., 28(14):2725-2729 (1998).
Bates, R.B. & Janda, K.D., “High-Yield Benzyne Synthesis of Diaryl Ethers”,J. Org. Chem., 47:4374-4376 (1982).
Baudoin, O., et al., “Palladium-Catalyzed Borylation of Ortho-Substituted Phenyl Halides and Application to the One-Pot Synthesis of 2,2′-Disubstituted Biphenyls”,J. Org. Chem., 65:9268-9271 (2000).
Benaglia, M., et al., “Synthesis of Pyridylstannanes from Halopyridines and Hexamethyldistannane with Catalytic Palladium”,Tetrahedron Ltrs., 38(27):4737-4740 (1997).
Bernaerts, P., et al., “Histamine H3antagonist thioperamide dose-dependently enhances memory consolidation and reverses amnesia induced by dizocilpine or scopolamine in a one-trial inhibitory avoidance task in mice”,Bahav. Brain Res., 154:211-219 (2004).
Bienfait, B., et al., “β-Cyanocyclobutenone as a Highly Reactive Dienophile in Comparison to β-Cyanocyclopentenone”,Tetrahedron, 47(38):8167-8176 (1991).
Bjenning, C., et al., “Peripherally administered Ciproxifan elevates Hypothalamic Histamine Levels and Potently Reduces Food intake in the Sprague Dawley rat”,Abstracts, Intn'l Sendai Histamine Symposium, Sendai, Japan, #P30:449-452 (2000).
Bogert, M.T. & Husted, H.G., “Researches on Thiazoles. XVIII. The Synthesis of 2-Phenylbenzothiazole-5-Carboxylic Acid and Derivatives”,J. of the Amer. Chem. Soc., 54:3394-3397 (1932).
Black, W.C., et al., “2,3-Diarylcyclopentenones as Orally Active, Highly Selective Cyclooxygenase2 Inhibitors”,J. Med. Chem., 42:1274-1281 (1999).
Browman, K.E., et al., “Enhancement of prepulse inhibition of startle in mice by the H3receptor antagonists thioperamide and ciproxifan”,Behav. Brain Res., 153:69-76 (2004).
Burger, A., et al., “2-(4-Imidazoly1)cyclopropylamine”,Univ. of Virg., 33-35 (1969).
Burns, H.D., et al., “Chapt.26. PET Ligands for Assessing Receptor Occupancy in Vivo”,Ann. Rep. In Medicinal Chem., 36:267-276 (2001).
Burns, H.D., et al., “Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development”,Curr. Opin. In Chem. Biol., 3:388-394 (1999).
Carroll, F.I., et al., “Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2-exo′2-(2′-Substituted 5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine Analogues”,J. Med. Chem., 44:2229-2237 (2001).
Chen, Z., et al., “Effects of histamine on MK-801-induced memory deficits in radial maze performance in rats”,Brain Research, 839:186-189 (1999).
Chen, Z., et al., “Pharmacological effects of carcinine on histaminergic neurons in the brain”,Brit. J. of Pharmacology, 143:573-580 (2004).
Cheng, Y.-C. & Prusoff, W. H., “Relationship Between the Inhibition Constant (KI) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I50) of an Enzymatic Reaction*”,Biochem. Pharmacology, 22:3099-3108 (1973).
Clapham, J. & Kilpatrick, G.J., “Thioperamide, the selective histamine H3receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse”,Eur. J. of Pharmacology, 259:107-114 (1994).
Cowart, M., et al., “4-(2-[2-(R)-Methylpyrrolidin-1-yl]bensofuran-5-yl)benzonitrile and Related 2-Aminoethylbensofuran H3Receptor Antagonists Potently Enhance Cognition and Attention”,J. Med. Chem., 48:38-55 (2005).
Dannley, R.L. & Zazaris, D.A., “The Synthesis of 2-Aminobenzenethiol Hydrochlorides”,Can. J. Chem., 43:2610-2612 (1965).
Del Almeida, M.A.M.R. & Izquierdo, I., “Memory Facilitation by Histamine”,Arch. Int.. Pharmacodyn, 283:193-198 (1986).
Delaunois, A., et al., “Modulation of acetylcholine, capsaicin and substance P effects by histamine H3receptors in isolated perfused rabbit lungs”,Eur. J. of Pharmacology, 277:243-250 (1995).
Della, E. W., et al., “Bridgehead Carbocations: A Solvolytic Study of 1-Bromobicylco[1.1.1]pentane and Its Bridgehead-Substituted Derivatives”,J. Am. Chem. Soc., 116:6159-6166 (1994).
Dimitriadou, V., et al., “Functional relationship between mast cells and C-sensitive nerve fibres evidenced by histamine H3-receptor modulation in rat lung and spleen”,Clin. Sci., 87:151-163 (1994).
Duméry, V. & Blozovski, D., “Development of amygdaloid cholinergic mediation of passive avoidance learning in the rat”,Exp. Brain Res., 67:61-69 (1987).
Dvorak, C.A., et al., “4-Phenoxypiperidines: Potent, Conformationally Restricted, Non-Imidazole Histamine H3Antagonists”,J. Med. Chem., 48:2229-2238 (2005).
Esbenshade, T.A., et al., “Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3receptor antagonist”,Biochem. Pharmacology, 68:933-945 (2004).
Esbenshade, T.A., et al., “Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrroilidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: 1. Potent and Selective Histamine H3Receptor Antagonist with Drug-Like Properties”,J. of Pharmacology&Ex. Ther., 313(1):165-175 (2005).
Fitzsimons, C., et al., “Histamine receptors signaling in epidermal tumor cell lines with H-ras gene alterations”,Infl. Res., 47(Suppl 1):S50-S51 (1998).
Fox, G.B., et al., “Effects of histamine H3receptor ligands GT-2331 and ciproxifan in a repeated acquitition avoidance response in the spontaneously hypertensive rat pup”,Beh. Brain Res., 131:151-161 (2002).
Fox, G.B., et al., “Identification of novel H3receptor (H3R) antagonists with cognition enhancing properties in rats”,Infl. Res., 52(Suppl 1):S31-S32 (2003).
Fox, G.B., et al., “Two Novel and Selective Nonimidazole H3Receptor Antagonists A-304121 and A-317920: II. In Vivo Behavioral and Neurophysiological Characterization”,J. of Pharmacology&Exp. Ther., 305(2):897-908 (2003).
Fox, G.B., et al., “Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl]-benzofur
Cowart Marlon D.
Sun Minghua
Zhao Chen
Zheng Guo Zhu
Abbott Laboratories
Chen Portia
Shameem Golam M
LandOfFree
Benzothiazole cyclobutyl amine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiazole cyclobutyl amine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazole cyclobutyl amine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4133183